PROSTAVISION

WIPO WIPO 2021

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark PROSTAVISION was filed as Word mark on 07/26/2021 at the World Intellectual Property Organization.

Trademark Details Last update: August 11, 2023

Trademark form Word mark
File reference 1629862
Register number 018383591
Countries Australia Brazil Canada Switzerland China United Kingdom Japan Norway Russia United States of America (USA)
Base trademark EU No. 018383591, May 25, 2021
Application date July 26, 2021
Expiration date July 26, 2031

Trademark owner

Trademark representatives

Wiener Str. 91 01219 Dresden DE

goods and services

05 Pharmaceutical and veterinary products; pharmaceutical and veterinary products for the diagnosis of diseases of the prostate; pharmaceutical and veterinary products for the treatment of diseases of the prostate; pharmaceutical and veterinary products for the diagnosis of cancer; pharmaceutical and veterinary products for the treatment of cancer; medical and veterinary preparations; medical and veterinary preparations for the diagnosis of diseases of the prostate; medical and veterinary preparations for the treatment of diseases of the prostate; medical and veterinary preparations for the diagnosis of cancer; medical and veterinary preparations for the treatment of cancer; dietetic foods and products for medical or veterinary purposes; dietetic foods and products for medical or veterinary purposes for the diagnosis of diseases of the prostate; dietetic foods and products for medical or veterinary purposes for the treatment of diseases of the prostate; dietetic foods and products for medical or veterinary purposes for the diagnosis of cancer; dietetic foods and products for medical or veterinary purposes for the treatment of cancer; nutritional supplements for humans and animals; nutritional supplements for the diagnosis of diseases of the prostate; nutritional supplements for the treatment of diseases of the prostate; nutritional supplements for the diagnosis of cancer; nutritional supplements for treating cancer; chemical preparations for medical or pharmaceutical purposes; chemical preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate; chemical preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate; chemical preparations for medical or pharmaceutical purposes for the diagnosis of cancer; chemical preparations for medical or pharmaceutical purposes for the treatment of cancer; biological preparations for medical or pharmaceutical purposes; biological preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate; biological preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate; biological preparations for medical or pharmaceutical purposes for the diagnosis of cancer; biological preparations for medical or pharmaceutical purposes for the treatment of cancer; preparations for use in medical diagnostic processes; preparations for use in medical diagnostic processes relating to the diagnosis of diseases of the prostate; preparations for use in medical diagnostic processes relating to the diagnosis of cancer; diagnostic preparations and materials

Trademark history

Date Document number Area Entry
February 17, 2023 2023/8 Gaz CA Rejection
January 10, 2023 2023/2 Gaz GB Rejection
January 4, 2023 2023/1 Gaz AU RAW: Rule 18ter(2)(i) GP following a provisional refusal
December 8, 2022 2022/49 Gaz NO Rejection
November 4, 2022 2022/46 Gaz CN Rejection
October 28, 2022 2022/44 Gaz CH Rejection
October 19, 2022 2022/42 Gaz BR Rejection
September 27, 2022 2022/39 Gaz RU RAW: Rule 18ter(2)(ii) GP following a provisional refusal
September 1, 2022 2022/35 Gaz JP Rejection
June 8, 2022 2022/24 Gaz US Rejection
April 7, 2022 2022/14 Gaz CN Rejection
February 28, 2022 2022/9 Gaz RU Rejection
December 7, 2021 2021/50 Gaz AU Rejection
November 29, 2021 Correction
July 26, 2021 EM Registration

ID: 141629862